FreeStyle Libre 3 Continuous Glucose Monitoring System— 510(k) K212132

Substantially Equivalent

Abbott Diabetes Care, Inc.

FDA 510(k) clearance K212132 for FreeStyle Libre 3 Continuous Glucose Monitoring System, Substantially Equivalent on 2022-05-26. Applicant: Abbott Diabetes Care, Inc.. Device class: 2.

Clearance details

Applicant
Abbott Diabetes Care, Inc.
Product code
Code QLG
Device class
Class 2
Regulation
21 CFR 862.1355
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Alameda, CA, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code QLG

view all

More clearances from Abbott Diabetes Care, Inc.

view all

Adverse events under product code QLG

product code QLG
Death
27
Injury
40,773
Malfunction
107,857
Other
6
Total
148,663

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Recalls naming K212132

K-number listed on FDA's recall record

Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K212132.

Data sourced from openFDA. This site is unofficial and independent of the FDA.